Jivi 2000 Unit (Antihemophilic Factor (Recombinant, B-Domain Deleted, Pegylated) POWDER FOR SOLUTION) 2000 UNIT

JIVI 2000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This powder for solution is designed for intravenous administration and is manufactured by Bayer Inc.

Strength

2000 UNIT

Manufacturer / TM Owner

BAYER INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JIVI 2000 Unit is primarily used for the treatment and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. This medication is formulated to replace the missing clotting factor IX, which helps control bleeding. It is often used in situations where rapid clotting is necessary, such as during surgery or after an injury. Patients may also use it as a preventive measure to reduce the frequency of bleeding episodes.

Side Effects

JIVI 2000 Unit works by replacing the missing clotting factor IX in the blood, which helps to form a stable blood clot. This can reduce the duration and severity of bleeding episodes. Some users may experience common side effects such as headache, nausea, or mild allergic reactions. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare provider.

Precautions & Warnings

JIVI 2000 Unit should be handled with care and stored according to the manufacturer's instructions to maintain its effectiveness. It is important to follow proper administration techniques to ensure safe and effective use. Patients should be monitored for any signs of allergic reactions or other adverse effects. This medication should only be used under the supervision of a healthcare professional.

Avoid Interactions

JIVI 2000 Unit may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the effectiveness of this medication. Always consult with a healthcare professional before starting any new medication.

Frequently Asked Questions

JIVI 2000 Unit is used to treat and prevent bleeding episodes in patients with hemophilia B.

JIVI 2000 Unit is administered intravenously after reconstituting the powder with the provided solution.

Common side effects may include headache, nausea, and mild allergic reactions.

Yes, JIVI 2000 Unit can be used to reduce the frequency of bleeding episodes in patients with hemophilia B.

JIVI 2000 Unit should be used under the supervision of a healthcare professional to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.